Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-21

Clinical Trial Update: Naltrexone Neuroimaging [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial update on naltrexone neuroimaging in early-stage research for eating disorders, including binge eating and purging concerns; trial status comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Eating Disorders, Binge Eating | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2023-08-21